NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)
The NIH Director’s New Innovator Award supports early stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are
| Agency | National Institutes of Health |
|---|---|
| Status | Forecasted |
| Opportunity number | RFA-RM-26-002 |
| Posted date | 12/11/2025 |
| Award ceiling | 475,000 |
| Award floor | 475,000 |
| Estimated total funding | 23,000,000 |
| Expected number of awards | 30 |
| Who can apply | Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government, excluding the NIH Intramural Research Program (NIH IRP);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions). |
| Assistance Listing (CFDA) | 93.310 |
| Description | The NIH Director’s New Innovator Award supports early stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director’s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund . |
| Agency contact | NewInnovatorAwards@mail.nih.gov |
| Official listing | https://www.grants.gov/search-results-detail/360987 |